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Atrial Fibrillation Patterns and Risks of Subsequent Stroke, Heart
Failure, or Death in the Community
Steven A. Lubitz, MD, MPH; Carlee Moser, PhD; Lisa Sullivan, PhD; Michiel Rienstra, MD, PhD; Jo~ao D. Fontes, MD; Mark L. Villalon, MD;
Manju Pai, MD; David D. McManus, MD, ScM; Renate B. Schnabel, MD, MSc; Jared W. Magnani, MD, MSc; Xiaoyan Yin, PhD; Daniel Levy,
MD; Michael J. Pencina, PhD; Martin G. Larson, ScD; Patrick T. Ellinor, MD, PhD;* Emelia J. Benjamin, MD, ScM*
Background-—Atrial ﬁbrillation (AF) patterns and their relations with long-term prognosis are uncertain, partly because pattern
deﬁnitions are challenging to implement in longitudinal data sets. We developed a novel AF classiﬁcation algorithm and examined
AF patterns and outcomes in the community.
Methods and Results-—We characterized AF patterns between 1980 and 2005 among Framingham Heart Study participants who
survived ≥1 year after diagnosis. We classiﬁed participants based on their pattern within the ﬁrst 2 years after detection as
having AF without recurrence, recurrent AF, or sustained AF. We examined associations between AF patterns and 10-year survival
using proportional hazards regression. Among 612 individuals with AF, mean age was 72.510.8 years, and 53% were men. Of
these, 478 participants had ≥2 electrocardiograms (median, 3; limits 2 to 23) within 2 years after initial AF and were classiﬁed as
having AF without 2-year recurrence (n=63, 10%), recurrent AF (n=162, 26%) or sustained AF (n=207, 34%), although some (n=46,
8%) were indeterminate. Of 432 classiﬁed participants, 363 died, 75 had strokes, and 110 were diagnosed with heart failure
during the next 10 years. Relative to individuals without AF recurrence, the multivariable-adjusted mortality was higher among
people with recurrent AF (hazard ratio [HR], 2.04; 95% conﬁdence interval [CI], 1.26 to 3.29) and sustained AF (HR, 2.36; 95% CI,
1.49 to 3.75).
Conclusions-—In our community-based AF sample, only 10% had AF without early-term (2-year) recurrence. Compared with
individuals without 2-year AF recurrences, the 10-year prognosis was worse for individuals with either sustained or recurrent AF.
Our proposed AF classiﬁcation algorithm may be applicable in longitudinal datas ets. ( J Am Heart Assoc. 2013;2:e000126 doi:
10.1161/JAHA.113.000126)
Key Words: atrial ﬁbrillation • heart failure • mortality • pattern • risk • stroke
A trial ﬁbrillation (AF) is associated with substantial risksof stroke, heart failure, and death.1 AF may be episodic and may recur.
2–8 The AF classiﬁcation scheme endorsed by
major cardiovascular societies classiﬁes individuals according
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to temporal patterns.1 A single AF episode is described as
ﬁrst detected. Recurrent AF is described as paroxysmal if an
episode lasts ≤7 days and is self-terminating or as persistent
if it lasts >7 days or is not self-terminating. AF is considered
permanent if efforts to restore sinus rhythm are either
abandoned or are regarded as unsuccessful.
The existing classiﬁcation scheme provides standardized
nomenclature for describing AF patterns.1,9 However, this
scheme is limited because it is based on consensus opinion
rather than pathophysiological or experimental information.
Application of the current AF classiﬁcation scheme in
observational studies has been challenging because of
several factors. First, distinction between paroxysmal and
persistent AF is predicated on knowledge of episode
duration. In observational studies, rhythm status may be
ascertained at a single encounter, and therefore it may not be
possible to determine if spontaneous cardioversion has
occurred within 7 days. Second, classiﬁcation of persistent
versus permanent AF may depend on patient- or pro-
vider-level factors rather than the intrinsic pattern of AF.
Speciﬁcally, patient symptoms and provider willingness to
perform cardioversion or use an antiarrhythmic agent to
restore sinus rhythm affect the distinction between persistent
and permanent AF. Third, AF classiﬁcation is ambiguous
when individuals have episodes that both do and do not
self-terminate within 7 days.
The descriptors paroxysmal, persistent, and permanent
have been widely used in studies describing the longitudinal
course of AF. However, deﬁnitions have deviated substantially
from the guidelines and differ between studies.2–7,10–18 As a
result of these and other limitations,9 ambiguity exists
regarding AF pattern frequency in the community and
relations between AF type and long-term prognosis.
We sought to develop a simpliﬁed AF pattern classiﬁcation
scheme that would minimize subjectivity in pattern classiﬁ-
cation and be applicable in longitudinal community-based
study settings. Given the aforementioned challenges of
imposing conventional AF pattern deﬁnitions, we character-
ized AF patterns as either ﬁrst detected without recurrence,
recurrent, or sustained during the 2 years following detection
among community-dwelling participants enrolled in the Fra-
mingham Heart Study. Using this classiﬁcation scheme we
further aimed to examine AF pattern frequencies in the
community and determine relations between speciﬁc patterns
and long-term clinical outcomes.
Methods
Participants
We identiﬁed participants from the Framingham Heart Study
Original19 and Offspring20 cohorts with ﬁrst-detected AF
between January 1, 1980, and December 31, 2005. The
Boston University Medical Center Institutional Review Board
approved study protocols, and all participants signed consent
forms at each examination cycle.
Assessment of AF
At each Framingham Heart Study clinic examination,
participants’ medical histories, physical examinations, and
electrocardiograms were obtained to ascertain symptoms and
ﬁndings suggestive of cardiovascular disease. Each partici-
pant’s primary physician was notiﬁed of the Framingham
electrocardiographic ﬁndings, including AF. Records of all
interim hospitalizations for cardiovascular disease were
sought for review. Participants were classiﬁed as having AF
if either atrial ﬂutter or ﬁbrillation was present on an
electrocardiogram obtained at a Framingham Heart Study
clinic visit or encounter with an external clinician, was present
on Holter monitoring, or was noted in hospital records. After
ﬁrst-detected AF, all subsequent Framingham Heart Study
clinic visits and acquired external healthcare encounters
(outpatient and hospital) were reviewed for evidence of AF. If
the rhythm remained stable during a hospitalization, only 1
electrocardiogram was coded. If the rhythm varied during a
hospitalization, the ﬁrst episode of AF, the ﬁrst episode of
sinus rhythm, and the ﬁnal electrocardiogram rhythm were
recorded. Cardioversion attempts and successes were sys-
tematically ascertained (see Data S1). Two physicians adju-
dicated ﬁrst-detected AF events and ≥1 adjudicated
subsequent encounter.
Figure 1. Illustrative example of atrial ﬁbrillation pattern classiﬁca-
tion. Individuals were classiﬁed as having various atrial ﬁbrillation
patterns on the basis of the cardiac rhythm pattern during the 2 years
following ﬁrst-detected atrial ﬁbrillation. After pattern classiﬁcation,
the occurrence of clinical events during the subsequent 10 years was
assessed. See text for detailed description of pattern deﬁnitions. AF
indicates atrial ﬁbrillation; NSR, normal sinus rhythm.
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Deﬁnition of AF Patterns
We included participants with ≥2 recorded electrocardiograms
and ≥1 year between the electrocardiogram with ﬁrst-detected
AF and last electrocardiogram to avoid AF associated with early
mortality (ie, within 1 year). Follow-up began after ﬁrst--
detected AF. We classiﬁed patterns as AF without recurrence,
recurrent, or sustained on the basis of the cardiac rhythm
pattern during the 2-year period following ﬁrst-detected AF
(Figure 1). We did not reclassify individuals during follow-up
after the initial classiﬁcation period. We performed classiﬁca-
tion using 1-, 2-, and 4-year windows but used 2-year
classiﬁcation windows in our analysis to minimize the number
of unclassiﬁed individuals while accounting for intercurrent
stroke, heart failure, or death events during the classiﬁcation
period (Figure 2). If participants died during the classiﬁcation
period, classiﬁcations were made on the basis of available data
that occurred until that point. Based on the ﬁrst 2 years after
initial AF detection, participants were classiﬁed as follows:
• AF without 2-year recurrence was deﬁned as sinus rhythm
without any subsequent AF episodes observed after
ﬁrst-detected AF.
• Recurrent AF was deﬁned as AF with sinus rhythm of any
duration between 2 AF episodes, including a successful
cardioversion.
• Sustained AF was deﬁned as the absence of sinus rhythm or
successful cardioversion after ﬁrst-detected AF.
• Indeterminate patterns included rhythms other than sinus
or AF or those in which a sequence of electrocardiograms
included consecutive AF followed by sinus rhythm at the
end of the classiﬁcation window (because AF recurrence
could not be veriﬁed without examining beyond the
classiﬁcation window).
• Inadequate data refers to individuals with only 1 electro-
cardiogram during the classiﬁcation window.
Ascertainment of Covariates, Stroke, Heart
Failure, and Death
We ascertained participant characteristics at Framingham
Heart Study clinic examinations (see Data S1). We included
characteristics from the closest examination before and within
8.5 years of ﬁrst-detected AF. Framingham Heart Study
Figure 2. Number of participants classiﬁed and number of interim events according to duration of classiﬁcation window after ﬁrst-detected atrial
ﬁbrillation. The number of participants in the sample who were classiﬁed as having atrial ﬁbrillation without recurrence, recurrent atrial ﬁbrillation,
or sustained atrial ﬁbrillation differed according to the length of the classiﬁcation window because of differing numbers of electrocardiograms
available for review. Classiﬁcation windows of 1, 2, and 4 years are displayed. Below the bar graph are the numbers of incident strokes, heart failure
events, and deaths that occurred before the end of each classiﬁcation period. Individuals with such events during the classiﬁcation period were
excluded from analyses examining relations between patterns and that respective clinical event. AF indicates atrial ﬁbrillation; HF, heart failure.
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participants are prospectively followed for the occurrence of
cardiovascular events. A panel of 3 Framingham Heart Study
investigators adjudicated strokes and heart failure events on
the basis of review of acquired medical records and Framing-
ham data based on published criteria.21 For strokes (including
transient ischemic attacks), the panel included a neurologist.
Statistical Analysis
We estimated the 10-year cumulative incidence of stroke, heart
failure, or death using the Kaplan-Meier method. Person-time
beganwith classiﬁcation 2 years followingﬁrst-detectedAF.We
examined differences in the unadjusted cumulative incidence of
clinical outcomes according to AF pattern using the log-rank
statistic. We examined adjusted associations between 2-year
AF patterns and outcomes using multivariable Cox proportional
hazards regression.22 In the primary analysis, we examined
associations between AF patterns classiﬁed in the ﬁrst 2 years
and subsequent 10-year risk of death. We contrasted associ-
ations between death and each pattern with one another. In the
secondary analyses, we studied relations between AF patterns
and 10-year risks of stroke and heart failure.
Models considered established risk factors for each respec-
tive outcome on the basis of published prediction algorithms,
which were entered directly (covariates are listed in the legend
for Table 2).21,23 Analyses of stroke and heart failure excluded
individuals with prevalent stroke and heart failure, respectively.
Individuals with clinical events that occurred during the classi-
ﬁcation window were excluded from analyses of the respective
modeled clinical events. All the multivariable models included
terms for each of the comparator patterns — recurrent,
sustained, indeterminate, and inadequate — for comparison to
the referent pattern, adjusted for important clinical risk factors.
Participants in our analysis were followed through December 31,
2009, to their last exam, health history update, or death.
Follow-up was censored at 10 years, last follow-up, loss to
follow-up, or death for analyses of stroke and heart failure.
Proportional hazards assumptions were tested with multiplica-
tive interaction terms between covariates and survival time.
The a priori signiﬁcance threshold was P<0.05 using
2-sided tests. We used the log-rank test with the observed
numbers of participants in the comparison groups and the
observed 10-year event rates to estimate our power to detect
associations between patterns and clinical outcomes.24 We
estimated we would have 80% power to detect associations
between recurrent AF and AF without 2-year recurrence with
hazard ratios of at least 1.73 for death, 2.22 for stroke, and
2.47 for heart failure. We estimated we would have 80%
power to detect associations between sustained AF and AF
without 2-year recurrence of at least 1.70 for death, 2.16 for
stroke, and 2.40 for heart failure. Analyses were performed
using SAS version 9.2 for Windows.22
Results
Of 1821 participants with AF and available electrocardio-
graphic data, 1758 were from the Original and Offspring
cohorts. Of these, 1338 had ﬁrst-detected AF between 1980
and 2005. Among the 612 participants who survived ≥1 year
after AF detection, the mean age was 72.510.8 years, and
327 (53%) were men (Table 1). Using the initial 2-year period
after ﬁrst-detected AF to classify patterns, 478 individuals
were classiﬁed using a median of 3 (limits, 2 to 23)
electrocardiograms. Sixty-three (10%) had AF without 2-year
recurrence, 162 (26%) had recurrent AF, and 207 (34%) had
sustained AF, whereas 46 (8%) had indeterminate patterns.
Among those with AF without 2-year recurrence, 4 (6%) had a
history of heart failure, 17 (27%) had a history of myocardial
infarction, and 9 (14%) had prior coronary artery bypass
surgery. Table 1 displays the baseline characteristics, clinical
settings where ﬁrst-detected AF was identiﬁed, and average
numbers of electrocardiograms on which classiﬁcations
were based. Details regarding cardioversion attempts and
antiarrhythmic and anticoagulation use are detailed in Table S1.
Shorter classiﬁcation periods (1 year) resulted in the
inability to classify 279 (46%) of 612 participants owing to the
infrequency of acquired electrocardiograms during the period
(Tables S2 and S3). In contrast, longer classiﬁcation periods
(4 years) were accompanied by the inability to classify only 24
(4%) of individuals at the expense of many intercurrent
strokes, heart failure diagnoses, or deaths, thereby precluding
inclusion of these individuals in analyses examining associ-
ations between patterns and respective clinical outcomes
(Figure 2).
Regardless of the length of the classiﬁcation window, AF
without recurrence was rare. The proportion of participants
with AF without recurrence during the classiﬁcation window
was 6% using 1-year classiﬁcation windows and slightly
higher, at 12%, using 4-year windows (because of the greater
number of classiﬁable participants when using the longer
classiﬁcation window).
Of 432 participants with AF classiﬁed in the ﬁrst 2 years,
363 died, 75 had a stroke, and 110 were diagnosed with heart
failure during the next 10 years. Figure 3 displays the 10-year
cumulative incidence of stroke, heart failure, or death following
classiﬁcation. Cumulative incidence curves for the composite
of clinical events are provided in Figure S3. The median time to
the ﬁrst of the clinical events was 3.1 years following the
classiﬁcation window (range, 0.007 to 9.96 years). Among
individuals without a clinical event, the median follow-up time
was 10 years (range, 0.760 to 10 years).
In the primary analysis, mortality was higher among
individuals with either recurrent AF (multivariable-adjusted
hazard ratio [HR], 2.04; 95% conﬁdence interval [CI], 1.27 to
3.29; P=0.003) or sustained AF (HR, 2.36; 95% CI, 1.49 to
DOI: 10.1161/JAHA.113.000126 Journal of the American Heart Association 4
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3.75, P=0.003), compared with those with AF without 2-year
recurrence (Table 2). The magnitude of risk associated with
both recurrent and sustained AF was not attenuated by
adjustment for comorbid conditions. We did not observe a
signiﬁcant difference in mortality between groups with
recurrent and sustained AF (P=0.33).
In secondary analyses (Table 2), incident heart failure risk
was higher among participants with recurrent AF compared
Table 1. Characteristics of the 612 Participants Included in the Analysis by Early AF Pattern
Characteristic Overall
AF Without 2-Year
Recurrence Recurrent AF Sustained AF Indeterminate Inadequate Data
No. of participants 612 63 (10) 162 (26) 207 (34) 46 (8) 134 (22)
No. of electrocardiograms 3.22.3 2.91.3 5.12.9 3.21.6 3.31.5 10
First-detected AF identified at FHS* 132 (22) 6 (10) 6 (4) 64 (31) 3 (7) 53 (40)
Age, y 7311 7111 7211 7510 7112 7011
Men 327 (53) 37 (59) 86 (53) 105 (51) 26 (57) 73 (54)
Body mass index, kg/m2 285 28.14.5 28.25.1 28.05.5 28.45.4 27.25.0
Systolic blood pressure, mm Hg 14122 14322 14222 14421 13719 13824
Antihypertensive therapy 290 (54) 36 (63) 76 (52) 97 (54) 26 (59) 55 (47)
Smoker 84 (16) 7 (12) 17 (12) 22 (12) 7 (16) 31 (27)
Diabetes mellitus 87 (16) 9 (16) 22 (15) 36 (20) 10 (23) 10 (9)
Heart rate, bpm 6813 6612 6612 7015 6512 6813
Left ventricular hypertrophy 28 (5) 5 (9) 9 (6) 11 (6) 0 3 (3)
Clinically significant heart murmur 77 (15) 7 (12) 16 (12) 39 (22) 3 (7) 12 (11)
History of heart failure 79 (13) 4 (6) 26 (16) 34 (16) 5 (11) 11 (8)
History of myocardial infarction 116 (19) 17 (27) 42 (26) 23 (11) 11 (24) 23 (17)
History of coronary artery bypass surgery 36 (6) 9 (14) 17 (10) 6 (3) 4 (9) 0 (0)
Within 30 days of incident AF 14 (2) 5 (8) 5 (3) 2 (1) 2 (4) 0 (0)
History of stroke 74 (12) 5 (8) 24 (15) 24 (12) 8 (17) 13 (10)
Data are shown as meanstandard deviation or number (%). AF indicates atrial ﬁbrillation.
*Compared with detection in a hospital or emergency department, by an outside clinician, on an outside electrocardiogram or Holter monitor, or by history alone. Detection at FHS refers
to detection on a Framingham Heart Study electrocardiogram or Holter monitor.
Figure 3. Cumulative incidence of stroke, heart failure, and death by atrial ﬁbrillation pattern. The cumulative incidence of (A) stroke, (B) heart
failure, and (C) death is displayed stratiﬁed by atrial ﬁbrillation pattern over the 10 years of follow-up after atrial ﬁbrillation pattern classiﬁcation.
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with those without recurrence and was not attenuated by
adjustment for heart failure risk factors (HR, 2.53; 95% CI,
1.19 to 5.38; P=0.02). We did not observe a signiﬁcant
association between sustained AF and heart failure relative to
participants with AF without 2-year recurrence (HR, 1.23; 95%
CI, 0.56 to 2.67; P=0.61). Heart failure risk differed signiﬁ-
cantly between recurrent and sustained AF (P=0.02).
Stroke risk did not differ signiﬁcantly among individuals
with recurrent (HR, 1.84; 95% CI, 0.77 to 4.38; P=0.17) or
sustained AF (HR, 1.32; 95% CI, 0.55 to 3.18; P=0.54), relative
to those without a 2-year AF recurrence. Results of primary
and secondary analyses for individuals with indeterminate
patterns or with insufﬁcient data for classiﬁcation are
displayed in Table S4.
Discussion
In our community-based sample of individuals with incident
AF, we applied a simpliﬁed classiﬁcation algorithm on the
basis of cardiac rhythm at multiple times to characterize AF
patterns and their associations with clinical outcomes. Few
individuals (10%) presented without AF on a subsequent
electrocardiogram within 2 years. Recurrent (26%) or sus-
tained (34%) AF was common and was associated with about
a 2-fold increased risk of mortality compared with individuals
without a 2-year recurrence of AF. Overall, individuals with AF
were at substantial risk of morbidity, with greater than two
thirds experiencing incident stroke, heart failure, or death
within about a decade of their ﬁrst-detected AF episode. Our
ﬁndings implicate heterogeneity in both the frequency of AF
patterns and the clinical implications of particular patterns.
Comparison of results between studies examining the
longitudinal course of AF is challenging, in part because AF
pattern deﬁnitions have been applied differently.2–7,10–18,25
Previous deﬁnitions have relied on heterogeneous AF episode
durations for pattern classiﬁcation and have variably
attempted to distinguish AF patterns other than paroxysmal
from one another. Our approach to classifying AF patterns on
the basis of the rhythm over a preceding time interval is
applicable to the clinical setting and similar to that suggested
by the American College of Cardiology and American Heart
Association clinical data standards committee.26 We used a
2-year window for classiﬁcation rather than the suggested
1-year period to ensure sufﬁcient density of encounters with
Table 2. Association Between Early AF Patterns and Death, Heart Failure, and Stroke Among Individuals With Incident AF
AF Without 2-Year Recurrence Recurrent AF Sustained AF
Total number with specific pattern 63 162 207
Primary outcome
Death
No. of events/person-years 29/431 87/678 141/852
Adjustment HR (95% CI) P HR (95%) CI P
Age and sex Referent 1.91 (1.25 to 2.90) 0.003 1.99 (1.33 to 2.97) <0.001
Multivariable* Referent 2.04 (1.27 to 3.29) 0.003 2.36 (1.49 to 3.75) <0.001
Secondary outcomes
Heart failure
No. of events/person-years 12/360 29/401 29/595
Adjustment HR (95% CI) P HR (95% CI) P
Age and sex Referent 2.08 (1.06 to 4.07) 0.03 1.08 (0.54 to 2.13) 0.84
Multivariable† Referent 2.53 (1.19 to 5.38) 0.02 1.23 (0.56 to 2.67) 0.61
Stroke
No. of events/person-years 9/352 24/570 22/621
Adjustment HR (95% CI) P HR (95% CI) P
Age and sex Referent 1.52 (0.70 to 3.27) 0.29 1.15 (0.53 to 2.50) 0.73
Multivariable* Referent 1.84 (0.77 to 4.38) 0.17 1.32 (0.55 to 3.18) 0.54
All models were adjusted for participants with indeterminate patterns as well as those with inadequate data for classiﬁcation. AF indicates atrial ﬁbrillation; HR, hazard ratio; CI, conﬁdence
interval.
*Adjusted for age, sex, smoking status, systolic blood pressure, diabetes mellitus, history of heart failure, history of myocardial infarction, clinically signiﬁcant murmur, and
electrocardiographic left ventricular hypertrophy.
†Adjusted for age, sex, systolic blood pressure, heart rate, electrocardiographic left ventricular hypertrophy, clinically signiﬁcant murmur, body mass index, diabetes mellitus, and history of
coronary heart disease.
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electrocardiograms for classiﬁcation in our observational data
set.
Our ﬁndings extend previous observations regarding AF
pattern frequency. In the Euro Heart Survey of AF, comprised
primarily of individuals with AF enrolled in the hospital setting,
46% of 621 individuals with ﬁrst-detected AF did not have a
recurrent episode within 1 year.15 In contrast, our ﬁndings
suggest that AF without recurrence is rare in the community,
even when restricting our follow-up to 1 year (6%). In the
prospective Etude en Activite Liberale de la Fibrillation
Auriculaire study of patients from cardiology practices in
France, 22% presented with paroxysmal AF.6 In an analysis
from the General Practice Research Database from the UK
from 1996 that included 1888 individuals with ﬁrst-detected
AF, AF was classiﬁed as paroxysmal in 28% and chronic in the
remainder.17 In individuals with ﬁrst-detected lone AF referred
to a single cardiovascular practice in Italy between 1966 and
1995, 55% were identiﬁed as having paroxysmal AF and the
remainder with chronic AF at the time of AF diagnosis.5 These
data support our observation that AF frequently recurs early
after detection.
Our results also extend previous data regarding the
relations between AF patterns and long-term prognosis. In
our cohort, mortality was increased about 2-fold among
participants with recurrent or sustained AF relative to those
without recurrence 2 years after detection. This ﬁnding
contrasts an analysis of 270 patients with AF from the Mayo
Clinic, in which permanent AF was not associated with
increased mortality after multivariable adjustment.16
Two primary hazards of AF are heart failure and stroke, both
of which serve as proximate risk factors for death. We
observed an estimated 2-fold increased heart failure risk
among individuals with recurrent AF compared with those with
AF without early recurrence. It is possible that the association
between heart failure and recurrent AF was attributable to
particular characteristics of recurrent AF. Alternatively, the
association may reﬂect reverse causation; in other words,
providers may have been more inclined to restore sinus rhythm
in patients with heart failure. The reason that sustained AF was
not associated with increased heart failure risk may reﬂect
exclusion of participants most likely to develop heart failure
during the 2-year classiﬁcation window or lack of power to
detect an association. We did not observe differences in stroke
risk among different AF patterns, ﬁndings that are generally
consistent with previous reports.27 However, we had limited
power to detect small differences (ie, HR<2) in stroke risk.
Strengths of our study include standardized ascertainment
of clinical outcomes and potential confounding factors in a
community-based cohort. Framingham Heart Study partici-
pants were followed longitudinally through routine study visits
and acquisition of intercurrent medical records from health-
care encounters.
Our study should be interpreted in the context of the
observational study design. First, in the absence of continu-
ous electrocardiographic monitoring, it is possible that AF
patterns were misclassiﬁed in some participants. Participants
who had only 1 electrocardiogram during the 2-year classi-
ﬁcation period (22%) could not be classiﬁed using our
algorithm, whereas 8% were indeterminate. A greater number
of participants had classiﬁable AF patterns as the duration of
the classiﬁcation window was extended. However, longer
classiﬁcation windows may have less direct clinical relevance
than 2-year windows. Furthermore, longer classiﬁcation
periods were associated with a greater number of intercurrent
stroke, heart failure, or death events during the classiﬁcation
window, thereby limiting an examination of the associations
between patterns and subsequent clinical outcomes. Never-
theless, we adjusted for participants with inadequate data or
indeterminate patterns in our analyses. Second, there is
potential for biased electrocardiogram sampling having
occurred in our cohort. Electrocardiograms between routine
Framingham Heart Study clinic research examinations were
not performed at standardized intervals, which may have
affected associations with clinical outcomes. Participants who
did not develop heart failure or strokes may have had fewer
healthcare encounters and therefore may have had fewer
electrocardiograms than others. Infrequent electrocardiogram
ascertainment is a limitation of most observational studies
and might be overcome in studies with frequent standardized
cardiac rhythm assessment such as clinical trials. Although an
analysis including only electrocardiograms from Framingham
Heart Study visits would offer standardized assessment of the
cardiac rhythm status, Framingham Heart Study visits were
spaced ≥2 years apart, limiting the sample size available for
evaluation, and may have less direct clinical relevance than
the analysis that we performed, which included assessments
during routine clinical care. In addition, limiting cardiac rhythm
assessment to Framingham visits alone would likely bias the
sample toward those with sustained AF. Third, residual
confounding remains possible despite adjustment for estab-
lished risk factors derived from published risk prediction
models.21,23 Fourth, although we did not attempt to distin-
guish between AF episodes that do and do not self-terminate,
there may be clinical differences associated with such AF
episodes. Fifth, our secondary analyses examining associa-
tions between AF patterns and heart failure and stroke had
limited power to detect small effect sizes. More events may be
necessary to determine whether the poorer prognosis among
those with recurrent or sustained AF is mediated by such
clinical events. Sixth, we studied middle-aged to older adults
of European ancestry; the generalizability to younger individ-
uals or other races/ethnicities remains to be determined.
Our observations have 2 main implications. First, our
results conﬁrm the heterogeneity of AF patterns in the
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community and demonstrate that AF without early recurrence
rarely occurs. AF without recurrence is associated with a
better prognosis than either recurrent or sustained AF, both of
which are associated with similar mortality. That so many
individuals had sustained AF at presentation raises questions
of whether such individuals had a period of unrecognized and
progressive AF prior to arrhythmia detection or instead
developed sustained AF at the outset.
Second, our ﬁndings imply that a simpliﬁed classiﬁcation
system that minimizes subjectivity may be applicable in the
context of observational data sets, electronic health records,
or clinical trials when the cardiac rhythm is ascertained at
multiple points over time. In these contexts, knowledge of
episode duration, self-termination of episodes, and provider
intent to restore sinus rhythm are frequently unknown.
Application of such an algorithm may facilitate examination
of the effectiveness of interventions for AF, cost-effectiveness
analyses, and quality-of-life assessments. Furthermore, appli-
cation of such an algorithm may enhance future efforts to
determine the inﬂuence of AF progression on health out-
comes. Our classiﬁcation system is only applicable to other
studies in which sufﬁcient density of rhythm assessment is
available.
Conclusions
In our community-based cohort, few individuals with newly
detected AF presented without an early-term recurrence, yet
their long-term prognosis appeared better than that for
individuals with either recurrent or sustained AF. No substantial
difference in prognosis was observed between individuals with
either recurrent or sustained AF. A simpliﬁed AF classiﬁcation
algorithm that minimizes subjectivity may be applicable in the
context of large data sets, yet requires validation. Identiﬁcation
of the speciﬁc causes of increased mortality associated with
recurrent or sustained AF needs further investigation.
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SUPPLEMENTAL METHODS 
 
Cardioversion assessment 
Cardioversions were systematically ascertained and classified as unsuccessful when AF 
was noted within 24 hours of the cardioversion attempt, or when it was described as 
unsuccessful in the medical record. Otherwise cardioversions were classified as 
successful. 
 
Clinical covariate assessment 
Participants were classified as having heart failure on the basis of two major or one 
major and two minor clinical criteria.1 Major criteria included paroxysmal nocturnal 
dyspnea or orthopnea, rales on auscultation, third heart sound, radiographic pulmonary 
edema, distended neck veins, increased venous pressure, hepatojugular reflux, 
significant weight loss on diuretic therapy, and increasing radiographic cardiomegaly. 
Minor criteria were comprised of night cough, ankle edema, dyspnea on exertion, pleural 
effusion, hepatomegaly, radiographic pulmonary vascular redistribution, tachycardia, and 
decrease in vital capacity. Diabetes was diagnosed if the Framingham Heart Study 
fasting glucose was ≥126 mg/dL, non-fasting blood glucose ≥200 mg/dL, or if a 
participant was using hypoglycemic medications. Owing to incomplete 
echocardiographic data on our sample, a clinically significant cardiac murmur was 
diagnosed in the presence of a systolic murmur that was at least grade three of six in 
intensity, or if any diastolic murmur was auscultated by a Framingham Heart Study clinic 
physician. Blood pressure was measured in the seated position twice by the 
Framingham Heart Study physician. The body mass index was calculated as the weight 
in kilograms divided by the height in meters squared. Current smoking was defined as 
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the self-reported regular use of cigarettes in the year preceding the examination. 
Coronary heart disease included a history of nonfatal myocardial infarction, angina 
pectoris, or coronary insufficiency. Electrocardiographic left ventricular hypertrophy was 
defined by presence of increased voltage and a strain pattern. Heart rate was 
ascertained at the time of a Framingham Heart Study examination. 
 
Detailed adjustment for association testing 
Analyses for incident stroke or death were adjusted for age, sex, smoking status, systolic 
blood pressure, diastolic blood pressure, prevalent heart failure, prevalent myocardial 
infarction, clinically significant heart murmur, and electrocardiographic left ventricular 
hypertrophy.2 Analyses for heart failure were adjusted for age, sex, systolic blood 
pressure, heart rate, electrocardiographic left ventricular hypertrophy, clinically 
significant heart murmur, body mass index, diabetes mellitus, and history of coronary 
heart disease.3  
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Supplemental Table 1. Cardioversions, antiarrhythmics, and anticoagulation among 612 participants 
during the two-year classification period.  
 
Therapy (per individual) AF without two-year recurrence Recurrent Sustained Indeterminate 
Inadequate 
data 
N with pattern 63 162 207 46 134 
Successful cardioversions       
1 5 (8) 40 (25) 0 (0) 4 (9) 6 (4) 
≥ 2 0 (0) 12 (7) 0 (0) 0 (0) 0 (0) 
Antiarrhythmic medication*      
Any 20 (32) 88 (54) 20 (10) 18 (39) 25 (19) 
Amiodarone 1 (2) 19 (12) 20 (10) 18 (39) 25 (19) 
Non-amiodarone 19 (30) 77 (48) 17 (8) 15 (33) 22 (16) 
Antithrombotic medication†      
Any 47 (75) 127 (78) 133 (64) 32 (70) 54 (40) 
Warfarin 19 (30) 85 (52) 93 (45) 20 (43) 24 (18) 
Non-warfarin 32 (51) 70 (43) 43 (21) 17 (37) 29 (22) 
*Refers to any recorded use ever during the two-year classification period. 
†Defined as warfarin, aspirin, or clopidogrel use. 
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Supplemental Table 2. Characteristics of the 612 participants included in the analysis by early AF pattern according to one- and 
four-year windows. 
  
Characteristic Overall 
AF without two-year 
recurrence 
Recurrent AF Sustained AF Indeterminate Inadequate data 
One year window 
N participants 612 35 (6) 96 (16) 136 (22) 66 (11) 279 (46) 
N ECGs 2.3 ± 1.7 2.9 ± 1.2 4.5 ± 2.2 2.7 ± 1.2 2.9 ± 1.1 1 ± 0 
Age, y 74 ± 10 72 ± 12 73 ± 11 77 ± 10 74 ± 10 74 ± 10 
Male 327 (53) 23 (66) 49 (51) 71 (52) 39 (59) 145 (52) 
Four Year Window 
N participants 612 74 (12) 239 (39) 250 (41) 25 (4) 24 (4) 
N ECGs 4.9 ± 3.3 3.6 ± 1.6 6.5 ± 4.1 4.2 ± 2.1 4.4 ± 1.9 1 ± 0 
Age, y 74 ± 10 70 ± 10 74 ± 11 77 ± 9 73 ± 12 70 ± 13 
Male 327 (53) 49 (66) 122 (51) 129 (52) 13 (52) 14 (58) 
 
Values are mean±SD or n (%) 
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Supplemental Table 3. Number of classified individuals by duration of classification 
window. 
 Classification pattern 
Classification 
window 
AF without  
recurrence Recurrent Sustained 
Inadequate  
data Indeterminate 
One year  35 96 136 66 279 
Two years 63 162 207 46 134 
Four years 74 239 250 25 24 
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Supplemental Table 4. Association between early AF patterns and death, heart failure, and stroke among 
individuals classified with indeterminate patterns or inadequate data. 
 AF without two-
year recurrence 
Indeterminate Inadequate data 
Total N with specific pattern 63 46 134 
Primary Outcome 
Death      
No. of events / person-years 29 / 431 24/283  82/810  
Adjustment  HR 95% CI P HR 95% CI P 
Age and sex Referent 1.09 (0.64-1.88) 0.95 1.51 (0.99-2.30) 0.06 
Multivariable* Referent 1.25 (0.69-2.26) 0.46 1.87 (1.15-3.04) 0.01 
Secondary Outcomes 
Heart failure      
No. of events / person-years 12 / 360 13/227  37/664  
Adjustment  HR 95% CI P HR 95% CI P 
Age and sex Referent 1.40 (0.63-3.07) 0.41 1.15 (0.58-2.26) 0.70 
Multivariable† Referent 1.34 (0.55-3.26) 0.52 1.72 (0.77-3.85) 0.19 
Stroke      
No. of events / person-years 9 / 352 4/243  16/698  
Adjustment  HR 95% CI P HR 95% CI P 
Age and sex Referent 0.58 (0.18-1.89) 0.37 0.87 (0.39-1.98) 0.74 
Multivariable* Referent 0.75 (0.22-2.60) 0.65 1.11 (0.45-2.75) 0.83 
All models are adjusted for participants with indeterminate patterns as well as those with inadequate data for classification. 
*Adjusted for age, sex, smoking status, systolic blood pressure, diabetes mellitus, history of heart failure, history of myocardial 
infarction, clinically significant heart murmur and ECG left ventricular hypertrophy. 
† Adjusted for age, sex, systolic blood pressure, heart rate, ECG left ventricular hypertrophy, clinically significant heart 
murmur, body mass index, diabetes mellitus, and history of coronary heart disease.  
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Supplemental Figure 1. Cumulative incidence of the composite of stroke, heart failure, or 
death by atrial fibrillation pattern.  
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